1Timmer CJ,Sitsen JM,Delbressine LP. Clinical pharmacokinetics of mirtazapine[J].Clinical Pharmacokinetics,2000,(6):461-474.doi:10.2165/00003088-200038060-00001.
2Cipriani A,Furukawa TA,Salanti G. Comparative efficacy and acceptability of 12 new-generation antidepressants:a multipletreatments meta-analysis[J].The Lancet,2009.746-758.
3Amini H,Aghayan S,Jalili SA. Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder:a double-blind,randomized trial[J].Journal of Clinical Pharmacy and therapeutics,2005.133-138.doi:10.1111/j.1365-2710.2004.00585.x.
4García Campayo J. Effectiveness of mirtazapine in the treatment of depression with associated somatic symptoms[J].Actas Espa olas de Psiquiatría:ACEPSI,2008.25-32.
5Kang EⅡ,Lee IS,Chung SK. Mirtazapine versus venlafaxine for the treatment of somatic symptoms associated with major depressive disorder:a randomized,open-labeled trial[J].Psychiatry Research,2009.118-123.doi:10.1016/j.psychres.2008.06.021.
6Han C,Pae CU,Lee BH. Venlafaxine versus mirtazapine in the treatment of undifferentiated somatoform disorder:a 12-week prospective,open-label,randomized,parallel-group trial[J].Clin Drug Investig,2008.251-261.
7Kim SW,Shin IS,Kim JM. Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression[J].Psychiatry and Clinical Neurosciences,2008.75-83.
8Chen CC,Lin CS,Ko YP. Premedication with mirtazapine reduces preoperative anxiety and postoperative nausea and vomiting[J].Anesthesia and Analgesia,2008.109-113.doi:10.1213/01.ane.0000289636.09841.bc.
9Pae CU. Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting[J].Progress in Neuro-Psychopharmacology & Biological Psychiatry,2006.1143-1145.
5Fishbain DA.Approaches to treatment decisions for psyehiatric comorbidity in the management of the chronic pain patient.Med Clin North Am,1999,83:737 -760.
